Pfizer CBD Gummies

CBDISTILLERY

Buy CBD Oil Online

Pfizer CBD Gummies Reviews 45 Rigoff Quit Smoking 40Scam Or Legit41 VANCOUVER, British Columbia, July 23, 2019 (GLOBE NEWSWIRE) — ICC International Cannabis Corp. (CSE: WRLD.U)(FWB: 8K51)(OTC: WLDCF) (the “Company” or…

Pfizer CBD Gummies Reviews – Rigoff Quit Smoking (Scam Or Legit)

Pfizer CBD Gummies are a top-selling CBD product designed with a natural blend in which a lot of natural and pain-curing ingredients are mixed so that this CBD gummy product can promote good health to people. This pain-curing formula makes sure that users are able to live a healthy and pain-free lifestyle. This is the best way to consume CBD, which has various therapeutic benefits.

We all dream to live a wealthy and luxurious life and to make this dream come true, we strive very hard in our job and try to meet all the standards to succeed. In an attempt to earn and achieve more than the others, we choose to give up on many significant things such as healthy eating habits, daily exercises routines, performing yoga, pranayama, and we skip all the physical movements. In the race of earning a lot of money, we are bound to neglect our health and fitness and due to this, we suffer from various health issues.

When we have big roles and lots of responsibilities then it is very common to take the stress and be anxious. But when this stress and anxiety take the form of bigger health issues than actual mental torments start to happen in the life of many people. And it is a fact that we all are human, we can not live without being stressed and anxious and that’s why sometimes it is okay to face some stress and anxiety. But do not let these small mental health issues take a toll on your life and health. Here we have come up with a solution called Pfizer CBD Gummies that are natural and made to heal pain, stress, depression, and various other mental torments of the users. As per the makers of this product, these CBD gummies are labeled as 100% effective and useful in eliminating chronic pain, joint pain, bone pain, headache, and various other torments of the body.

How Pfizer CBD Gummies Are Beneficial For The Mental Health Of The People?

Pfizer CBD Gummies are a CBD-based natural formula and can be consumed by people in tasty and flavourful gummies. From curing chronic pain to regulating the blood flow of the body, these CBD-infused gummies have helped many people in overcoming stress, depression, anxiety, mental headache, and several other health issues. The consumption of this CBD gummy product has made it possible for the consumers to intake CBD and needed nutrients and nourishment.

How Pfizer CBD Gummies Are Composed Of? Or What Natural Ingredients Are Used In The Making?

Do you suffer from stress and anxiety and because of these issues managing all day work and duties is impossible? Then, here you do not need to be worried as here Pfizer CBD Gummies are a perfect solution for people who are above the age of 18 and meet all the conditions of the product. These gummies are prepared from a variety of natural ingredients, which are proven to be pain-healing and stress-killing in nature and offer good mental health to the users.

All the components used in these gummies are scientifically proven as natural, effective, and completely free from various harmful and mind-altering substances. Cbd is considered to be one of the main ingredients used in these gummies and it is quite effective and beneficial for offering several therapeutic benefits to the users.

What Are the Health Advantages Of Consuming Pfizer CBD Gummies?

What Is The Procedure Of Consuming Pfizer CBD Gummies?

In order to use these gummies, users need to make sure that they visit the official site and read all the instructions that are related to the consumption process of these gummies. And as per the official site, consumers can chew 1-2 gummies at a time and once in the morning and once in the evening. These gummies will make sure that users are having various therapeutic benefits if these gummies are consumed daily and properly. Pfizer CBD Gummies will bring a lot of health advantages if people use this product daily and by following all the terms and conditions.

What Is The Procedure Of Buying Pfizer CBD Gummies?

If you want to buy this CBD gummy product, then you will have to go to the official site of the product. To reach the official site, you can find the link in this article and after reaching the site, you can buy this product. Pfizer CBD Gummies can be purchased by filing a form with the basic details such as name, address, city, and so on. Once all these formalities to buy the product are done, then the product will arrive at the home of the buyers within a week. And users who find any difficulty in buying these CBD gummies then they can contact customer care of the product.

See also  CBD Oil 40

The Consumption Of Pfizer CBD Gummies Will Not Beneficial In The Following Situations:-

The Ultimate Words On Pfizer CBD Gummies:-

These gummies are quite known for having non-psychoactive properties and with the help of which users of this CBD gummy product will not get high and they will not have any unwanted effects. This CBD gummy product has got popularity and praises in this modern and developed world for perfectly dealing with mental and physical related ailments. To buy this pain-curing formula, users can easily make a visit to the official site of the product through this article.

Pfizer CBD Gummies Reviews – Rigoff Quit Smoking (Scam Or Legit)

Pfizer CBD Gummies Reviews – Rigoff Quit Smoking (Scam Or Legit)

7Newswire
6th August 2021, 03:02 GMT+10

Pfizer CBD Gummies are a top-selling CBD product designed with a natural blend in which a lot of natural and pain-curing ingredients are mixed so that this CBD gummy product can promote good health to people. This pain-curing formula makes sure that users are able to live a healthy and pain-free lifestyle. This is the best way to consume CBD, which has various therapeutic benefits.

We all dream to live a wealthy and luxurious life and to make this dream come true, we strive very hard in our job and try to meet all the standards to succeed. In an attempt to earn and achieve more than the others, we choose to give up on many significant things such as healthy eating habits, daily exercises routines, performing yoga, pranayama, and we skip all the physical movements. In the race of earning a lot of money, we are bound to neglect our health and fitness and due to this, we suffer from various health issues.

When we have big roles and lots of responsibilities then it is very common to take the stress and be anxious. But when this stress and anxiety take the form of bigger health issues than actual mental torments start to happen in the life of many people. And it is a fact that we all are human, we can not live without being stressed and anxious and that’s why sometimes it is okay to face some stress and anxiety. But do not let these small mental health issues take a toll on your life and health. Here we have come up with a solution called Pfizer CBD Gummies that are natural and made to heal pain, stress, depression, and various other mental torments of the users. As per the makers of this product, these CBD gummies are labeled as 100% effective and useful in eliminating chronic pain, joint pain, bone pain, headache, and various other torments of the body.

How Pfizer CBD Gummies Are Beneficial For The Mental Health Of The People?

Pfizer CBD Gummies are a CBD-based natural formula and can be consumed by people in tasty and flavourful gummies. From curing chronic pain to regulating the blood flow of the body, these CBD-infused gummies have helped many people in overcoming stress, depression, anxiety, mental headache, and several other health issues. The consumption of this CBD gummy product has made it possible for the consumers to intake CBD and needed nutrients and nourishment.

How Pfizer CBD Gummies Are Composed Of? Or What Natural Ingredients Are Used In The Making?

Do you suffer from stress and anxiety and because of these issues managing all day work and duties is impossible? Then, here you do not need to be worried as here Pfizer CBD Gummies are a perfect solution for people who are above the age of 18 and meet all the conditions of the product. These gummies are prepared from a variety of natural ingredients, which are proven to be pain-healing and stress-killing in nature and offer good mental health to the users.

All the components used in these gummies are scientifically proven as natural, effective, and completely free from various harmful and mind-altering substances. Cbd is considered to be one of the main ingredients used in these gummies and it is quite effective and beneficial for offering several therapeutic benefits to the users.

What Are the Health Advantages Of Consuming Pfizer CBD Gummies?

What Is The Procedure Of Consuming Pfizer CBD Gummies?

In order to use these gummies, users need to make sure that they visit the official site and read all the instructions that are related to the consumption process of these gummies. And as per the official site, consumers can chew 1-2 gummies at a time and once in the morning and once in the evening. These gummies will make sure that users are having various therapeutic benefits if these gummies are consumed daily and properly. Pfizer CBD Gummies will bring a lot of health advantages if people use this product daily and by following all the terms and conditions.

What Is The Procedure Of Buying Pfizer CBD Gummies?

See also  Green Ape CBD Gummies Tinnitus

If you want to buy this CBD gummy product, then you will have to go to the official site of the product. To reach the official site, you can find the link in this article and after reaching the site, you can buy this product. Pfizer CBD Gummies can be purchased by filing a form with the basic details such as name, address, city, and so on. Once all these formalities to buy the product are done, then the product will arrive at the home of the buyers within a week. And users who find any difficulty in buying these CBD gummies then they can contact customer care of the product.

The Consumption Of Pfizer CBD Gummies Will Not Beneficial In The Following Situations:-

The Ultimate Words On Pfizer CBD Gummies:-

These gummies are quite known for having non-psychoactive properties and with the help of which users of this CBD gummy product will not get high and they will not have any unwanted effects. This CBD gummy product has got popularity and praises in this modern and developed world for perfectly dealing with mental and physical related ailments. To buy this pain-curing formula, users can easily make a visit to the official site of the product through this article.

Pfizer, Bristol-Myers Squibb, and Biogen Advisor, Dr. Alex Makriyannis, PhD, Joins ICC Funded Biosynthesis Cannabinoid Company; to Champion Cannabinoid Pharmaceutical Research and THC/CBD Edibles Application Mandates

July 23, 2019 00:05 ET | Source: ICC International Cannabis Corp. ICC International Cannabis Corp.

Vancouver, British Columbia, CANADA

VANCOUVER, British Columbia, July 23, 2019 (GLOBE NEWSWIRE) — ICC International Cannabis Corp. (CSE: WRLD.U)(FWB: 8K51)(OTC: WLDCF) (the “Company” or “ICC” or “International Cannabis”) is pleased to announce that the Company, alongside Biotii Technologies Corp. (“Biotii”) has entered into a cannabinoid pharmaceutical advisory agreement (the “Agreement”) with Pfizer, Bristol-Myers Squibb, and Biogen Advisor, Dr. Alexandros Makriyannis, PhD (“Dr. Makriyannis”). A professor of Chemistry and Chemical Biology in the Department of Medicinal Chemistry at Northeastern University, Dr. Makriyannis is credited with numerous scientific cannabinoid-centric achievements, including the discovery of cannabinoid receptor antagonists, as well as pioneering inmetabolically stable endocannabinoids.

Dr. Makriyannis will champion the Company’s pursuit of biosynthesizing cannabinoids identical to those found in nature, with the objective of standardizing pharmacological effects within the human endocannabinoid system. Highly specialized knowledge of cannabinoid biochemistry, as well as the macro human endocannabinoid system equips ICC and Biotii with a first mover competitive advantage to economically scale its synthesized cannabinoid platform.

By 2020, ICC and Biotii intends to establish processes to efficiently mass-produce CBD/THC in quantities of hundreds of metric tonnes per annum, which boast:

  • Stable and consistent yields;
  • Pharmaceutical-grade purities; and,
  • The lowest production costs in the space.

Biotii’s scalable synthesizing process will enable the manufacturing of enigmatic cannabis compounds, as well as THC and CBD at materially lower costs when compared with conventional cultivation and extraction processes. Traditional cultivation of cannabis plants for the purpose of extracting cannabidiolic acid (“CBDA”), THC and CBD is a time, labour and resource intensive endeavour that can result in depressed extraction yields of approximately 2.5 per cent.

Armed with a successful track record of generating cannabinoid centric intellectual property (“IP”), including the authoring of 37 related patents within the United States, Dr. Makriyannis will assist in guiding ICC funded Biotii with their corporate mandate of securing a robust portfolio of defendable IP. Dr. Makriyannis is exclusively qualified to ensure Biotii’s retains its competitive advantage as one of the first innovators to economically biosynthesize cannabinoids at industrial scale.

Underpinning his lifetime of achievements in academia and cannabis related research, including the design of cannabinoid receptor probes as early as 1995, Dr. Makriyannis was trained at the University of California, Berkeley, Tufts Medical School, as well as the Massachusetts Institute of Technology.

Dr. Makriyannis has lectured at over 110 institutions including preeminent, multinational pharmaceutical companies and academic centers such as Abbott Laboratories, the American Chemical Society, Harvard Medical School, Columbia University, and Yale. The Company’s new advisor permits Biotii and ICC with direct access to a vast network of global leaders within the cannabis research community. Dr. Makriyannis’ previous advisory clientele includes:

  • Pfizer;
  • Bristol Myers;
  • Biogen Idec;
  • Nestle;
  • Glaxo Wellcome;
  • Genaissance Pharmaceuticals;
  • MAKScientific;
  • Forest Laboratories;
  • Arqule Pharmaceuticals; and,
  • Aileron Therapeutics.

David Shpilt, Chief Executive Officer of International Cannabis stated: “Developing a scaled cannabinoid biosynthesis platform requires comprehensive knowledge of precise biochemical processes within the human metabolism of cannabinoids. Dr. Makriyannis affords ICC backed Biotii an unparalleled competitive advantage with his singular understanding of the human endocannabinoid system, as well as the specific underlying receptor interactions. With Dr. Makriyannis’ guidance, ICC and Biotii are better equipped than ever to produce the absolute highest quality of cannabinoids, far exceeding industry standards, within the cannabis, food, and pharmaceutical verticals.

“The fortuitous timing of Dr. Makriyannis appointment will function as a beachhead within ICC/Biotii’s pursuit of manufacturing high-quality cannabinoid inputs for the emerging cannabis-infused edibles, beverage and topical marketplace. His experience advising food conglomerates, such as Nestlé S.A is closely aligned with upcoming amendments to Health Canada regulations, including the recently announced schedule to legalize cannabis edibles in Q4 2019 or Q1 2020. Dr. Makriyannis further augments International Cannabis and Biotii capabilities in crafting highest quality edible cannabinoid products and natural biosynthesized additives for the cannabis industry.

See also  Just CBD Gummies 750mg Dosage

“The knowledge of cannabis plants, synthesized cannabinoids and human receptors brought by Dr. Makriyannis will guide ICC and Biotii in continuing to build a robust portfolio of meaningful intellectual property that will protect our proprietary processes from the initial biosynthesis of cannabinoids through the controlled metabolism of our cannabinoids within the human body, all while generating significant long-term investor value.”

Dr. Makriyannis’ deep-seated comprehension of the human endocannabinoid system is further demonstrated by 430 published research papers validated within the peer reviewed scientific journal arena. Collectively the aforementioned research papers have generated over 15,360 additional citations.

Dr. Makriyannis asserted: “As the scientific community’s global understanding of the human endocannabinoid system expands and social acceptance of cannabis increases, it is truly exciting to join Biotii and ICC in their pursuit of radical advancements within the biosynthesis of cannabinoids. Together we champion a long-term focus on discovering sustainable pharmaceutical applications for cannabis related medicines with the objective of improving patient outcomes.”

Throughout his esteemed career, Dr. Makriyannis has secured non-dilutable funding in the form of US$4 million in research grants awarded by the U.S. National Institute of Health (“NIH”). Dr. Makriyannis’ intricate knowledge of the scientific research grant model will provide ICC backed Biotii with a coveted opportunity to pursue for non-diluted funding, thus augmenting the Companies operational and research runway. Recent NIH grants and previous industry funding awards, spearheaded by Dr. Makriyannis include:

  • Cannabinoid Receptor 2 Signaling;
  • Supplementation of Omega-3 Fatty Acids during Pregnancy;
  • Candidate Medications for Cannabis Addiction: FAAH Inhibitors;
  • Cannabinergic Medications for Methamphetamine Addiction;
  • Endocannabinoid Active Sites as Therapeutic Targets;
  • Cannabimimetic Ligands and Drugs;
  • Training Program in Medications Development for Drugs of Abuse;
  • Novel Medications for Cannabis Dependence;
  • Endo Pharmaceuticals CB2 Selective Agonists;
  • Glaxo Wellcome Design and Synthesis of Antineoplastic Alkyl Lysophospholipids;
  • Glaxo Wellcome Antineoplastic Ether Lipids Molecular Mechanisms of Action;
  • WHO World Health Organization Research Award; and,
  • Pfizer Central Research Development of Porcine Somatotropin Receptor Binding Assays.

Dr. John Harrold, Biotii’s Chief Executive Officer and Co-Founder stated: “Professor Makriyannis has achieved global cannabis related research for more than three decades. In joining Biotii’s scientific advisory board, Makriyannis offers not only his expertise of individual cannabinoid molecules, but also his knowledge of ligand receptor interactions within the human endocannabinoid system. By leveraging direct access to targeted intel on CB1 receptor and CB2 receptor interactions, ICC and Biotii hopes to gain an additional competitive advantage in building the world’s first scaled cannabinoid biosynthesis platform.”

ABOUT INTERNATIONAL CANNABIS

ICC International Cannabis, through its subsidiaries, has operating assets and is developing a world-class platform for cultivation, extraction, formulation and distribution across the globe in the United Kingdom, Denmark, Poland, Switzerland, Germany, Macedonia, Bulgaria, Serbia, Croatia, Greece, Italy, Portugal, Malta, Colombia, Argentina, Australia, South Africa and Lesotho.

ON BEHALF OF THE ICC INTERNATIONAL CANNABIS CORP BOARD OF DIRECTORS

For ICC French inquiries:
Remy Scalabrini, Maricom Inc.
E: [email protected] T: +001 (888) 585-MARI

Learn more about ICC by visiting our website at: https://intlcannabiscorp.com/

THE CSE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

Notice Regarding Forward Looking Information:

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: political changes in Canada and internationally, future legislative and regulatory developments involving cannabis in Canada and internationally, the Company’s ability to secure distribution channels in international jurisdictions, competition and other risks affecting the Company in particular and the cannabis industry generally.

The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward- looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

How useful was this post?

Click on a star to rate it!

Average rating / 5. Vote count:

No votes so far! Be the first to rate this post.